Exciting news from West Cancer Center: New Breast Cancer Drug Available at West Cancer Center Shows Great Promise in Phase 2 Clinical Study Ari VanderWalde, MD, MPH, Director of Clinical Research for the West Cancer Center and the Associate Vice Chancellor of Clinical Research at the University of Tennessee, says: “Palbociclib, if successful in Phase 3 trials, could be a medication that impacts the lives of untold numbers of patients and their families. We are encouraged to have access to the agent for our patients before it is available to the general public." For more: https://bit.ly/RFCtop
关于我们
The West Clinic has been the region’s premier provider of cancer care in the Mid-South for over 35 years. With a team second to none in breadth of expertise, dedication to excellence, and commitment to compassionate care, our multidisciplinary physician group is comprised of 39 specialists in Medical Oncology, Hematology, Gynecologic Oncology, Breast Surgery, Endocrinology, Diagnostic and Interventional Radiology, Radiation Oncology, Pain and Palliative Care, and other advanced medical care. With eleven locations in Memphis, TN; West TN; North MS; and West AR; patients across the Mid-South have greater access to the highest quality care available. The West Clinic’s clinical research program, under the direction of Lee S. Schwartzberg, MD, FACP, Medical Director, is internationally renowned. Over the past two decades, West Clinic has consistently been one of the first centers in the U.S. to gain experience and hasten the development of new drugs for breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, and many other diseases. Today, our researchers are investigating new drug therapies through participation in over 40 Phase I and late phase national clinical trials. For more information visit https://www.westclinic.com/research-2/clinical-trials/
- 网站
-
https://www.westclinic.com
The West Clinic的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 201-500 人
- 总部
- Memphis
- 类型
- 私人持股
地点
-
主要
获取路线
US，Memphis